Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;44(8):1214-1222.
doi: 10.1007/s00270-021-02839-9. Epub 2021 May 13.

Treatment of Hydatid Liver Cyst With Double Percutaneous Aspiration and Ethanol Injection Under Ultrasound Guidance: 6.5-Year Median Follow-up Analysis

Affiliations

Treatment of Hydatid Liver Cyst With Double Percutaneous Aspiration and Ethanol Injection Under Ultrasound Guidance: 6.5-Year Median Follow-up Analysis

Antonio Giorgio et al. Cardiovasc Intervent Radiol. 2021 Aug.

Abstract

Purpose: Although hydatid liver cyst (HLC) is a benign disease, treatment is recommended to avoid life-threatening complications. There are several treatment options for HLC: "wait-and-watch," medical or surgical or percutaneous treatment. The purpose of this study was to assess the long-term effectiveness of an alternative of the traditional percutaneous PAIR procedure, called double percutaneous aspiration and ethanol injection (D-PAI).

Materials and methods: This prospective, non-randomized study was conducted from 1988 to 2019 using DPAI procedure characterized by no reaspiration of the ethanol injected to replace the aspirated fluid and repetition of the procedure after 3-7 days.

Results: Two hundred and three patients with 290 HLCs underwent D-PAI. Two hundred and two HLC (160 patients) were univesicular cysts and 88 (43 patient) were multivesicular. Seventeen patients underwent one D-PAI session, 15 patients two sessions, and 18 up to four sessions. The follow-up ranged 0.9-21 years (median 6.5 years). On ultrasound, 188 cysts (64.8%) disappeared; 57 cysts (19.7%) became solid (inactive) and 45 (15.5%) showed a small inactive residual component. Parasitologic cure was very high. The overall response to D-PAI was higher than 90% considering also the procedures carried out after the first D-PAI at the time of recurrence. One patient died for anaphylactic shock. The hospital stay ranged 1-3 days. Smaller cysts (< 5 cm) healed sooner than larger cysts (p < 0.001).

Conclusions: Long-term analysis showed that D-PAI is a safe and effective option in percutaneous treatment of viable HLC, except for CE2/CE3b in which the recurrences can be observed. This inexpensive and simple procedure can be applied everywhere and especially in developing countries.

Keywords: Double percutaneous aspiration and injection; Hepatic cystic Echinococcosis; Ultrasound.

PubMed Disclaimer

References

    1. Kern P, Menezes da Silva A, Akhan O, et al. The echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol 2017;96:259–369. https://doi.org/10.1016/bs.apar.2016.09.006 .
    1. Giorgio A, Calisti G, de Stefano G, et al. Percutaneous treatment of hydatid liver cysts: an update. Recent Pat Antiinfect Drug Discov. 2012;7(3):231–6. https://doi.org/10.2174/157489112803521913 . - DOI - PubMed
    1. WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. 2003;85(2):253–61. https://doi.org/10.1016/s0001-706x(02)00223-1 . - DOI
    1. Eckert J, Gemmell MA, Meslin FX, Pawloski ZS, editors. WHO/OIE manual of echinococcosis in humans and animals: a public health problem of global concern. Paris: France, World Health Organization; 2001.
    1. Pakala T, Molina M, Wu GY. Hepatic Echinococcal cysts: A Review.J Clin Transl Hepatol. 2016;4(1):39–46. https://doi.org/10.14218/JCTH.2015.00036 . Epub 2016 Mar 15.

LinkOut - more resources